Skip to content
Screener

Vistagen Therapeutics, Inc. VTGN Q4 2025 earnings

Reported February 12, 2026 · After market close

Revenue$303.0KMiss by $61.4K
EPS-$0.45Beat by $0.06
Revenue estimate$364.4K
EPS estimate-$0.51

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$500.0K
EPS estimate-$0.37

FAQ

When did Vistagen Therapeutics, Inc. report Q4 2025 earnings?
Vistagen Therapeutics, Inc. (VTGN) reported Q4 2025 earnings on February 12, 2026 after market close.
What were Vistagen Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Vistagen Therapeutics, Inc. reported revenue of $303.0K and eps of $-0.45 for Q4 2025.
Did Vistagen Therapeutics, Inc. beat estimates in Q4 2025?
Revenue missed the consensus estimate of $364.4K by $61.4K. EPS beat the consensus estimate of $-0.51 by $0.06.
How did Vistagen Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 29.5% from $234.0K a year earlier and eps grew 2.2% from $-0.46.
Where can I find Vistagen Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-007715) and the 10-Q periodic report (0001628280-26-007718) directly on SEC EDGAR. The filing index links above go to sec.gov.